Recombinant Interferon Alfa-2b
A non-glycosylated recombinant interferon with antiviral and antineoplastic activities. Alfa interferons bind to specific cell-surface receptors, resulting in the transcription and translation of genes whose protein products mediate antiviral, antiproliferative, anticancer, and immune-modulating effects. [ ]
Term info
Recombinant Interferon Alfa-2b
- Alfatronol
- Glucoferon
- Heberon Alfa
- IFN alpha-2B
- INTERFERON ALFA-2B
- Interferon Alfa-2B
- Interferon Alpha-2b
- Interferon alfa 2b
- Intron A
- Recombinant Interferon Alfa-2b
- Sch 30500
- Urifron
- Viraferon
- interferon alfa-2b
- recombinant interferon alfa-2b
NCIT_C116978, NCIT_C128784, NCIT_C63923, NCIT_C157711, NCIT_C116977, NCIT_C157712
A drug used to treat some infections caused by viruses and several types of cancer. These include hairy cell leukemia, melanoma, and follicular lymphoma. It is a form of interferon alfa (a substance normally made by cells of the immune system) that is made in the laboratory. It is a type of biological response modifier.
98530-12-2, 99210-65-8
CTRP, FDA
Recombinant Interferon Alfa-2b
43K1W2T1M6
http://purl.obolibrary.org/obo/NCIT_C37274
Recombinant_Interferon_Alfa-2b
377523
462279
462279
Recombinant Interferon Alfa-2b
Pharmacologic Substance, Amino Acid, Peptide, or Protein
C0021735
C1953
Term relations
- Recombinant Interferon Alfa
- Chemical_Or_Drug_Has_Physiologic_Effect some Gene Regulation Process
- Chemical_Or_Drug_Has_Physiologic_Effect some Inhibition of Cell Proliferation
- Chemical_Or_Drug_Has_Physiologic_Effect some Cytokine Signaling Process
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Cytokine Receptor Activation
- Chemical_Or_Drug_Affects_Gene_Product some Interferon Alpha Receptor Complex
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation